List of Vendor Companies in Slovenia - 4

ACIES BIO is a biotechnology contract research organization offering state-of-the-art R&D services to pharmaceutical, chemical, biotech and food industries. We provide full support from idea conceptualization through research to product development. Combining biotechnology and synthetic organic chemistry expertise, we offer a comprehensive service, covering all key development steps for efficient production of biosynthetic natural products or their semi-synthetic derivatives, as well as entirely synthetic compounds. Working with some of the largest international companies, we provide to our clients full R&D support both in our laboratories as well as on-site at the client’s facilities. With experience and know-how in natural product (bio)synthesis, milestone-based approach to projects, innovativeness and flexibility, as well as competitive pricing, ACIES BIO aims to become the premier partner in R&D outsourcing for pharmaceutical companies.

BioSistemika specializes in custom software development, digitalization consulting, and development of laboratory software products. Over the past 10 years, we have worked with many laboratory instrument manufacturers and delivered software products that were tailored to our customer needs. We have completed several in vitro diagnostic (IVD) projects and non-IVD software projects for our customers for which we developed entire software product suites, starting from requirements, design specification, coding, and testing. For IVD, we are working in accordance with ISO 13485 and IEC 62304. We have vast experience in software-hardware integrations and are supporting standardization efforts that enable interoperability. BioSistemika also has immense experience with resolving compatibility with laboratory equipment, other software systems, connections between coding languages, big data storage, and analysis. We aim to empower scientists with professional software that has an excellent user experience. Years of experience in customizing software solutions gained us trusted partners. We cooperate with leading Life Science companies such as Gilson, Agilent, Alifax, ADInstruments, 4titude, and many others. BioSistemika has also consulted the most prominent companies about setting up a digitalization strategy. We help to implement it and build all the missing links by integrating existing software solutions or building new ones. We have successfully collaborated in multiple grant-funded R&D projects as well as lead international consortia. We have an experienced project management team and back office at our disposal, capable of coordinating and managing complex R&D activities, administration as well as the subsequent commercialization stages.

GenePlanet is the leading European provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests.   With over 15 years of experience in the market, GenePlanet collaborates with over 1000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries. The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures. GenePlanet adheres to the highest standards of quality and is constantly striving for new discoveries through its research and development efforts. With a presence in more than 35 countries worldwide and over 100,000 satisfied customers, GenePlanet has been recognised as one of the 1000 fastest-growing companies in the EU by the Financial Times and one of the Top 35 EU Unicorns by the European Commission.

We develop and manufactures market-leading CIM® monolithic chromatographic columns for the purification and analysis of large biomolecules, such as viruses, pDNA, and mRNA, which are applied in vaccines and gene therapies. Our Cornerstone® Biomanufacturing Development Services offer a comprehensive approach of integrated process development solutions and technology designed to improve the robustness and yield of large biomolecules production while improving the safety of therapeutic products.